Federal Finance Minister Scholz attends the opening of the development Bank ILB supports the establishment of
Potsdam Kleinmachnow – More and more high-tech companies in the pharmaceutical industry to settle in Brandenburg. The medical Start-up Ayna Analytics GmbH has now opened a modern laboratory at Europarc Dreilinden. There will in future be examined by means of a patented and unique in the world, method of analysis, drug destruction to all of your ingredients go. And the much faster and more cost-effective than current methods.
The diploma in pharmacist, and the pharmacist David Mainka, Managing Director of Ayna Analytics GmbH, said in the run-up to the opening: "We are delighted that we can now begin our new laboratory in the Europarc relate to. With a purely Cloud-based corporate environment and a special room air plant, this is on the latest state of the art. Thanks to a large Vault, which is approved for the storage of narcotics, we can carry out stability studies even in the case of medicinal products which fall under the narcotics act.“
Tillmann Topmastr, Chairman of the Board of Brandenburg development Bank, ILB, explained: "Each of the company's founding in Brandenburg is a win-win for our business location. I am particularly pleased, however, when innovative high-tech companies in us. Ayna Analytics followed with a patented technology, a promising business model – and in the increasingly important area of medical technology. Therefore, we support the company with a total of around € 1.3 million from the funding programmes GRW-G and BIG Digital. I wish Ayna Analytics to the best possible Start at the new location.“
Ayna Analytics will initially offer laboratory services to pharmaceutical companies and pharmacies. The EU requires the GMP guidelines that pharmaceutical manufacturers must have their products regularly to the correct active ingredient composition check. This usually happens procedures in external laboratories by means of classical analysis. Ayna Analytics offers the producers and pharmacies devices with which the analysis is based in the future, in-house and cloud can be carried out faster and more cost-effective.
The technological Background, the so-called near-infrared spectroscopy (NIR) in combination with 3D printing and a purely Cloud-forms-based, ultra-modern IT concepts. This is a method of using infrared radiation, information about the exact composition of a sample can be collected, for example, of a drug. This is also through glass and plastic, the samples do not have to consequently open and thus be destroyed.